XTCYF

XTACY THERAPEUTICS CORP by Xtacy Therapeutics Corp. (XTCYF)

About XTACY THERAPEUTICS CORP by Xtacy Therapeutics Corp. (XTCYF)

Pegasus Mercantile, Inc. engages in providing advisory services, debt, and equity funding in the mid to late stages of a target company’s development or in technologies that are developed and validated but may be in the early stage of commercialization in the medical cannabis, hemp, CBD, and biotechnical markets. It focuses on global wellness, psychedelics, mycology, hemp, and CBD, healthcare-related target companies, and its clinical studies and trials. The company was founded on August 31, 1998 and is headquartered in Vancouver, Canada.

Details

Daily high
--
Daily low
--
Price at open
--
52 Week High
$0.13
52 Week Low
$0.01
Market cap
617,700
Dividend yield
0.00%
Volume
--
Avg. volume
38
P/E ratio
-1.77

XTACY THERAPEUTICS CORP by Xtacy Therapeutics Corp. News

Details

Daily high
--
Daily low
--
Price at open
--
52 Week High
$0.13
52 Week Low
$0.01
Market cap
617,700
Dividend yield
0.00%
Volume
--
Avg. volume
38
P/E ratio
-1.77